In partnership with researchers from the VHA’s Quality Enhancement Research Initiative Program, the VHA Office of Connected Care, responsible for the VHA’s digital health strategy, launched the Veterans Engagement with Technology Collaborative (VET-C) cohort in 2017. A longitudinal data collection effort, the VET-C cohort combines veteran survey data collected over 3 timepoints with VHA administrative records [26]. The goal of the cohort is to support veteran engagement in the evaluation of VHA patient-facing technologies [26]. This manuscript reports the results of a cross-sectional analysis of data gathered predominantly as part of the third round of data collection efforts from the VET-C cohort to understand perspectives on what is most important to veterans when deciding whether to use DHTs, with the goal to inform implementation strategies that the VHA can leverage to support DHT adoption.

The VET-C cohort consists of a national sample of veterans who received care from 14 geographically distinct VHA facilities. These sites were selected purposefully to represent VHA facilities with high use of secure messaging supported by My HealtheVet (the VHA’s web-based patient portal), diverse segments of the veteran population, hubs for VHA research, and experience with technology rollouts. Data collection did not focus on a specific clinical setting. Veterans invited to the cohort were active users of VHA health care and technology users, defined as owning a cellular phone and having sent ≥5 secure messages through My HealtheVet in the previous year [26,27].

VET-C surveys were collected between 2017-2018, 2019-2020, and 2021-2022. As noted above, data for the variables reported in this analysis were primarily gathered in the third round of VET-C data collection from veterans who had responded to the first 2 rounds of surveys. Information about the first 2 rounds of VET-C survey data collection is published elsewhere [26-28].

Our recruitment procedures comprised several steps. Veterans were first mailed a copy of the third round VET-C survey along with a cover letter and postage-paid reply envelope. A follow-up mailing was then sent to nonrespondents approximately 4 weeks after the initial mailing to facilitate response. The survey was designed iteratively based on veteran feedback and Office of Connected Care leadership input and included a combination of validated items and customized questions.

Veterans were asked to report their sex, age, race and ethnicity, highest level of education, relationship status, self-perceived physical and mental health status [29], extent of health care received through the VHA (compared to community settings), and typical travel time (in minutes) from home to their VHA primary care doctor.

We further asked veterans to report technology access and ownership, technology use [30], and whether they are mobile health app users and health-related digital device users. We also asked veterans to report how easy it is for them to communicate with their VHA health care team.

We collected information on perceptions of what is important when deciding whether to use technology for health by asking veterans to rate various considerations as “very important,” “somewhat important,” or “not at all important” when deciding whether to use DHTs to help them manage their health. Response options included considerations at multiple levels, including those related to the health care system, the community, the patient themselves, and an open-ended “other” response option where respondents could list and rate considerations not otherwise included among the closed-ended response options.

We supplemented survey data with administrative data to identify chronic physical and mental health conditions from the prior 5 years that are prevalent among veterans and to fill in missing demographic data as necessary. We also used administrative data to calculate a prior-year comorbidity index score using the hierarchical condition community score [31,32]. The hierarchical condition community score factors in a person’s diagnoses, eligibility for Medicare and Medicaid services, sex, and age and commonly ranges from 0.9-1.7, with scores greater than 1 often interpreted as indicating poorer health [31-33].

We used descriptive statistics to characterize survey data, and chi-square analyses to compare perceptions of what veterans consider important when deciding whether to use technology for health, comparing those with and without prevalent chronic health conditions (ie, diabetes, hypertension, and chronic kidney disease) and prevalent mental health conditions (ie, depression, anxiety, and posttraumatic stress disorder). Analyses were conducted in Stata MP (version 14.2; StataCorp).

This work was reviewed by relevant VHA Institutional Review Boards and designated as program evaluation for quality improvement purposes, exempting it from further oversight (Program Guide 1200.21) [34]. Returning a survey was considered consent to participate. Data were deidentified and labeled with a unique ID number. Veterans were not compensated for their participation.

We invited 1373 veterans to complete a third-round survey. We removed 15 veterans from the denominator because their surveys were undeliverable or they had passed away. A total of 858 (63.2%) veterans returned a survey. We removed 1 veteran with unavailable health condition data from our analytic cohort.

As summarized in Tables 1 and 2, survey respondents were predominantly men (750/857, 87.5%), White (762/857, 88.9%), and older than 65 years of age (602/857, 70.2%). Over half (452/853, 53%) considered themselves early technology adopters. Most (736/849, 86.7%) reported currently using or previously having used ≥1 health-related digital devices and currently or previously using either VHA or non-VHA mobile health apps (639/815, 78.4%).

Considerations most frequently endorsed as “very important” included receiving secure messages through the VHA’s My HealtheVet web-based patient portal from one’s health care team about DHTs (561/766, 73.2%), knowing that one’s health care team will use the information entered into the DHTs to inform one’s care (427/756, 56.5%), having one’s provider recommend DHTs (402/764, 52.6%), having somewhere to get help with issues using DHTs (389/760, 51.2%), and having other members of one’s health care team recommend DHTs (345/760, 45.4%). These considerations did not significantly differ between veterans with or without prevalent chronic health conditions or prevalent mental health conditions.

The considerations most frequently endorsed as “not at all important” by veterans included the following: seeing information about DHTs on social media (533/756, 70.5%); having community support through Veteran Service Organizations, churches, libraries, or other organizations (501/754, 66.4); having other veterans encourage DHT use (430/758, 56.7%); having help from family, friends, or other important people to use DHTs (315/759, 41.6%); and receiving printed information about DHTs from the VHA (201/758, 26.5%). These considerations did not significantly differ between veterans with or without prevalent chronic health conditions. However, a greater proportion of veterans with (compared to without) prevalent mental health conditions reported the following considerations to be “very important”: seeing information about DHTs on social media (those with mental health conditions: 42/428, 9.8%; those without mental health conditions: 19/328, 5.8%; χ²₂=6.2; P=.05); having community support through Veteran Service Organizations, churches, libraries, or other organizations to use DHTs (with: 56/427, 13.1%; without: 25/327, 7.6%; χ²₂=7.9; P=.02); having other veterans encourage DHT use (with: 70/429, 16.3%; without: 24/329, 7.3%; χ²₂=15.9; P<.001); and having help from family, friends, or other important people to use DHTs (with: 106/431, 24.6%; without: 58/328, 17.7%; χ²₂=6.4; P=.04). Please see Table 3 for more details.

Understanding what matters most to patients when deciding to use DHTs can inform the development of strategies to support their adoption and use. For veterans who receive VHA care and are known technology users, our results suggest that the most important considerations are tied to the health care system and include receiving encouragement from health care team members to use DHTs, knowing DHT data will be used in care, and having help available when using DHTs. Conversely, our results suggest that the least important considerations for veterans who use VHA care and are known technology users when deciding to use DHTs are rooted outside the health care system, including social media and encouragement and support from peers or other community members, although the veterans in our sample with prevalent mental health conditions did place more importance on these considerations. These insights can be leveraged to promote different technology platforms as part of health care services and inform efforts to ensure that implementation strategies deployed align with patient preferences and values. They also reflect the relative importance in this context of different theoretical constructs posited to influence the adoption of new technologies, including sources of social influence and the perceptions of others deemed important to an individual [18,19].

From our findings, outreach and recommendations from care team members were most frequently endorsed as very important to decisions about DHT use. These findings are consistent with previous literature that highlights the importance of health care team member encouragement to veteran use of technologies for health [12,14,35,36], and similar findings have also emerged in other published studies of other patient populations [37,38]. This trend suggests that implementation strategies intended to bolster veteran DHT adoption and use must reflect care team member involvement to be optimally impactful. This could include emphasizing care team member endorsement of specific technologies and their potential value to veterans or affirmation that care team members will use the data that veterans gather and share through these technologies to inform clinical practice, a consideration that has also been highlighted as important in literature about nonveteran populations [39].

Uniquely, our findings highlight different approaches that can be useful for outreach and recommendations and how such approaches may have differential impacts among segments of patient populations. In this sample of veterans who are known technology users, receiving secure messages about DHTs through the VHA’s web-based patient portal was the consideration most frequently endorsed as very important when deciding to use DHTs. The VHA already uses its web-based patient portal to disseminate health promotion information, including information about new technologies [12]. Using the messaging feature of a web-based patient portal may be an efficient, low-cost way for health care teams to proactively communicate with patients about technologies they think could be helpful to them.

Beyond health care team–related factors, the availability of technical support was the second most frequent consideration endorsed as very important when deciding to use DHTs. Previously published reviews have also identified difficulties using technology and tech support availability as factors influencing patient use [40,41]. Although our survey did not ask veterans whether they thought such support should be offered by the VHA, we see such help and support as services that the VHA could provide to address this need. Such services are evident in recent VHA initiatives like Veteran Health Resource Centers, which provide hands-on support within VHA facilities to veterans, their informal caregivers, and staff who are interested in using VHA technology platforms [42].

Unlike previously published studies suggesting that leveraging communities, peers, and social media may facilitate the adoption of technology for health in certain contexts [43-45], the veterans in our sample less frequently endorsed peer and community support and information shared through social media as important considerations. Although peer-, community-, and social media–based resources may represent efficient and low-cost approaches to facilitating DHT use, health care systems should work to understand patient preferences and perspectives before relying too heavily on such approaches, which may be best suited for use among certain segments of their patient populations. Patients with mental health conditions may be one such example, where strategies grounded in community and peer support are well-positioned to enhance reach and engagement with DHTs.

The veterans in the VET-C cohort are known technology users. As such, our results may not generalize to the overall veteran population or other patient populations. This sample characteristic may also explain why receiving secure messages from one’s health care team through the VHA’s web-based patient portal was deemed such an important consideration. However, this finding parallels other findings regarding the importance that veterans place on health care team member recommendations when deciding whether to use DHTs [14,35]. Moreover, data from our sample of known technology users may not address considerations important to veterans who minimally or do not use technology when deciding to use DHTs. We must guard against overgeneralizing these findings so as not to inadvertently overlook the needs of patients for whom accessibility of care, and by extension DHTs, are formidable barriers. These groups may require alternative implementation strategies that more adequately reflect their situation [46,47]. Potentially high-impact future work could include replicating a survey similar to the one reported here with subsets of the veteran population who lack both ready access to DHTs and health care services. Cross-sectional survey data may also be influenced by recall, response, and social desirability biases. Finally, we cannot infer how our results may translate to actual technology adoption and use. Additional work is needed to develop and rigorously test implementation strategies to provide such insights.

Understanding what matters most to patients when deciding to use DHTs can inform strategies to enhance DHT use. This analysis represents an additional step towards foregrounding the perspective of patients as key stakeholders when designing implementation strategies to bolster adoption of health-related technology. Recommendations from health care team members and knowing their data will be used by their care team members in clinical care are more important considerations for veterans who use technology for health than information they may encounter through social media, community sources, or peers when deciding whether to adopt DHTs, although perceptions of importance regarding the latter may differ among patients with different conditions. Taken together, our results suggest that communication from health care team members to patients, perhaps either in-person or electronically, may be beneficial in many cases to promote DHT adoption and use. Future work should also examine these issues among veterans who may have a strong interest in using DHTs but are not yet DHT users and face various barriers to their adoption.